UPDATE 1-Novartis wins EU okay for first meningitis B vaccine

LONDON, Nov 16 (Reuters) - The first vaccine against meningitis B has been recommended for approval in Europe in a boost for its maker Novartis, which has struggled in the vaccines field against larger rivals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.